skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus

Journal Article · · Nature Reviews Microbiology
DOI:https://doi.org/10.1038/nrmicro3524· OSTI ID:1351402
 [1];  [2];  [3]
  1. Univ. of California, Riverside, CA (United States)
  2. Washington Univ., St. Louis, MO (United States)
  3. Icahn School of Medicine at Mount Sinai, New York, NY (United States)

Ebola viruses and Marburg viruses, members of the filovirus family, are zoonotic pathogens that cause severe disease in people, as highlighted by the latest Ebola virus epidemic in West Africa. Filovirus disease is characterized by uncontrolled virus replication and the activation of host responses that contribute to pathogenesis. Underlying these phenomena is the potent suppression of host innate antiviral responses, particularly the type I interferon response, by viral proteins, which allows high levels of viral replication. Here, in this Review, we describe the mechanisms used by filoviruses to block host innate immunity and discuss the links between immune evasion and filovirus pathogenesis.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
U.S. Department of Defense and the Defense Threat Reduction Agency; National Institutes of Health (NIH)
Grant/Contract Number:
U19 AI109945; R01 AI059536; U19 AI109664; U19 AI070489; R01 AI081914; HDTRA1-12-1-0051; HDTRA1-14-1-0013
OSTI ID:
1351402
Journal Information:
Nature Reviews Microbiology, Vol. 13, Issue 11; ISSN 1740-1526
Publisher:
Springer NatureCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 155 works
Citation information provided by
Web of Science

References (133)

Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key Event journal December 2003
Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression journal December 2009
Virus Infection Triggers SUMOylation of IRF3 and IRF7, Leading to the Negative Regulation of Type I Interferon Gene Expression journal July 2008
DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and Endothelial Cells journal January 2003
Marburgvirus Genomics and Association with a Large Hemorrhagic Fever Outbreak in Angola journal June 2006
Nitric Oxide Induces Cell Death by Regulating Anti-Apoptotic BCL-2 Family Members journal September 2009
Mechanisms of type-I- and type-II-interferon-mediated signalling journal May 2005
Evaluation of Immune Globulin and Recombinant Interferon‐α2b for Treatment of Experimental Ebola Virus Infections journal February 1999
Global Suppression of the Host Antiviral Response by Ebola- and Marburgviruses: Increased Antagonism of the Type I Interferon Response Is Associated with Enhanced Virulence journal February 2006
Response to Imported Case of Marburg Hemorrhagic Fever, the Netherlands journal August 2009
Haematological, Biochemical and Coagulation Changes in Mice, Guinea-pigs and Monkeys Infected with a Mouse-adapted Variant of Ebola Zaire Virus journal November 2001
Forty Years of Marburg Virus journal November 2007
A Novel Immunohistochemical Assay for the Detection of Ebola Virus in Skin: Implications for Diagnosis, Spread, and Surveillance of Ebola Hemorrhagic Fever journal February 1999
Marburgvirus Hijacks Nrf2-Dependent Pathway by Targeting Nrf2-Negative Regulator Keap1 journal March 2014
Effect of Human Recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant Activity journal December 1997
Ebola virus glycoprotein-mediated anoikis of primary human cardiac microvascular endothelial cells journal April 2004
Infectious Lassa Virus, but Not Filoviruses, Is Restricted by BST-2/Tetherin journal August 2010
Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats journal July 2009
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. journal April 1996
Anti-Tetherin Activities of HIV-1 Vpu and Ebola Virus Glycoprotein Do Not Involve Removal of Tetherin from Lipid Rafts journal March 2012
Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques journal December 2003
PACT, a protein activator of the interferon-induced protein kinase, PKR journal August 1998
Structure of the Ebola VP35 interferon inhibitory domain journal January 2009
Crystal Structure of Marburg Virus VP24 journal February 2014
Molecular Basis for Ebolavirus VP35 Suppression of Human Dendritic Cell Maturation journal August 2014
The Lack of Maturation of Ebola Virus-Infected Dendritic Cells Results from the Cooperative Effect of at Least Two Viral Domains journal April 2013
Modular Structure of PACT: Distinct Domains for Binding and Activating PKR journal March 2001
Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein journal January 2009
The Ebola virus VP35 protein functions as a type I IFN antagonist journal October 2000
Depletion of Peripheral Blood T Lymphocytes and NK Cells During the Course of Ebola Hemorrhagic Fever in Cynomolgus Macaques journal September 2004
Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment journal February 2015
Effects of Ebola Virus Glycoproteins on Endothelial Cell Activation and Barrier Function journal July 2005
Cell Adhesion Promotes Ebola Virus Envelope Glycoprotein-Mediated Binding and Infection journal April 2008
Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis journal October 2010
Molecular Determinants of Ebola Virus Virulence in Mice journal January 2006
An Upstream Open Reading Frame Modulates Ebola Virus Polymerase Translation and Virus Replication journal January 2013
Amino Acid Residue at Position 79 of Marburg Virus VP40 Confers Interferon Antagonism in Mouse Cells journal April 2015
Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection journal August 2011
VP24 Is a Molecular Determinant of Ebola Virus Virulence in Guinea Pigs journal November 2011
Host Response Dynamics Following Lethal Infection of Rhesus Macaques With Zaire ebolavirus journal November 2011
Isolation and Partial Characterisation of a new Virus Causing Acute HÆMorrhagic Fever in Zaire journal March 1977
Mutual Antagonism between the Ebola Virus VP35 Protein and the RIG-I Activator PACT Determines Infection Outcome journal July 2013
Ebola and Marburg Viruses Replicate in Monocyte‐Derived Dendritic Cells without Inducing the Production of Cytokines and Full Maturation journal December 2003
Ebola Virion Attachment and Entry into Human Macrophages Profoundly Effects Early Cellular Gene Expression journal October 2011
 5 1-Integrin controls ebolavirus entry by regulating endosomal cathepsins journal April 2009
Seasonal Pulses of Marburg Virus Circulation in Juvenile Rousettus aegyptiacus Bats Coincide with Periods of Increased Risk of Human Infection journal October 2012
The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide journal October 2009
Molecular Characterization of Guinea Pig-Adapted Variants of Ebola Virus journal November 2000
The Marburg Virus VP24 Protein Interacts with Keap1 to Activate the Cytoprotective Antioxidant Response Pathway journal March 2014
Studies of Reservoir Hosts for Marburg Virus journal December 2007
Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses journal February 2000
Structural and Functional Characterization of Reston Ebola Virus VP35 Interferon Inhibitory Domain journal June 2010
Preliminary report: isolation of Ebola virus from monkeys imported to USA journal March 1990
The Double-Stranded RNA-Binding Protein PACT Functions as a Cellular Activator of RIG-I to Facilitate Innate Antiviral Response journal April 2011
Virological and Serological Findings in Rousettus aegyptiacus Experimentally Inoculated with Vero Cells-Adapted Hogan Strain of Marburg Virus journal September 2012
The Ebola Virus VP24 Protein Prevents hnRNP C1/C2 Binding to Karyopherin α1 and Partially Alters its Nuclear Import journal November 2011
The Interferon-Induced Protein BST-2 Restricts HIV-1 Release and Is Downregulated from the Cell Surface by the Viral Vpu Protein journal April 2008
Ebola Virus Enters Host Cells by Macropinocytosis and Clathrin-Mediated Endocytosis journal November 2011
Studies of Ebola Virus Glycoprotein-Mediated Entry and Fusion by Using Pseudotyped Human Immunodeficiency Virus Type 1 Virions: Involvement of Cytoskeletal Proteins and Enhancement by Tumor Necrosis Factor Alpha journal December 2004
Filovirus replication and transcription journal March 2007
Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway journal November 2008
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu journal January 2008
RIG-I activation inhibits ebolavirus replication journal September 2009
Human Ebola virus infection results in substantial immune activation journal March 2015
Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro journal July 2007
The Ebola Virus Glycoprotein and HIV-1 Vpu Employ Different Strategies to Counteract the Antiviral Factor Tetherin journal November 2011
Structural basis for Marburg virus VP35-mediated immune evasion mechanisms journal November 2012
Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus journal December 2012
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak journal August 2014
Ebola Virus VP24 Targets a Unique NLS Binding Site on Karyopherin Alpha 5 to Selectively Compete with Nuclear Import of Phosphorylated STAT1 journal August 2014
A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: Implications for filovirus budding journal November 2000
Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection journal June 2005
Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells journal January 2011
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1 journal August 2011
Basic Residues within the Ebolavirus VP35 Protein Are Required for Its Viral Polymerase Cofactor Function journal August 2010
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. journal January 1996
A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus journal October 2004
Filovirus assembly and budding journal January 2006
The VP40 Protein of Marburg Virus Exhibits Impaired Budding and Increased Sensitivity to Human Tetherin following Mouse Adaptation journal October 2014
Phosphatidylserine receptors: Enhancers of enveloped virus entry and infection journal November 2014
Lymphocyte Death in a Mouse Model of Ebola Virus Infection journal November 2007
Ebola Virus Selectively Inhibits Responses to Interferons, but Not to Interleukin-1β, in Endothelial Cells journal April 1999
ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity journal February 2008
Emerging and reemerging of filoviruses book January 1996
Ebola Zaire Virus Blocks Type I Interferon Production by Exploiting the Host SUMO Modification Machinery journal June 2009
The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold journal February 2012
Dendritic Cells journal August 2001
Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses journal March 2003
Ebola Virus Glycoprotein Counteracts BST-2/Tetherin Restriction in a Sequence-Independent Manner That Does Not Require Tetherin Surface Removal journal May 2010
Markedly Elevated Levels of Interferon (IFN)‐σ, IFN‐α, Interleukin (IL)‐2, IL‐10, and Tumor Necrosis Factor‐α Associated with Fatal Ebola Virus Infection journal February 1999
The role of the Type I interferon response in the resistance of mice to filovirus infection journal June 2001
Transmission of Ebola Hemorrhagic Fever: A Study of Risk Factors in Family Members, Kikwit, Democratic Republic of the Congo, 1995 journal February 1999
Human Infection Due to Ebola Virus, Subtype Côte d'Ivoire: Clinical and Biologic Presentation journal February 1999
Discovery of an Ebolavirus-Like Filovirus in Europe journal October 2011
Ebola Virus Inhibits Induction of Genes by Double-Stranded RNA in Endothelial Cells journal December 1998
Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients journal April 1999
ORAL SHEDDING OF MARBURG VIRUS IN EXPERIMENTALLY INFECTED EGYPTIAN FRUIT BATS ( ROUSETTUS AEGYPTIACUS ) journal January 2015
Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses journal May 1998
A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever journal February 1999
Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury journal August 2000
Key Genomic Changes Necessary for an In Vivo Lethal Mouse Marburgvirus Variant Selection Process journal February 2011
Genomic Differences between Guinea Pig Lethal and Nonlethal Marburg Virus Variants journal November 2007
Reston ebolavirus in Humans and Animals in the Philippines: A Review journal November 2011
Pathogenesis of Ebola Hemorrhagic Fever in Primate Models journal December 2003
Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner journal September 2010
Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by Tetherin journal November 2008
Ebola Virus VP40-Induced Particle Formation and Association with the Lipid Bilayer journal June 2001
Functional CD8 + T Cell Responses in Lethal Ebola Virus Infection journal March 2008
An Interferon-α-Induced Tethering Mechanism Inhibits HIV-1 and Ebola Virus Particle Release but Is Counteracted by the HIV-1 Vpu Protein journal September 2007
Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes journal September 2010
Epidemiologic Investigation of Marburg Virus Disease, Southern Africa, 1975 * journal November 1978
Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35 journal January 2010
Development of a model for marburgvirus based on severe-combined immunodeficiency mice journal January 2007
The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3 journal July 2003
Evasion of Interferon Responses by Ebola and Marburg Viruses journal September 2009
Emergence of Zaire Ebola Virus Disease in Guinea journal October 2014
Interferon-stimulated genes: roles in viral pathogenesis journal June 2014
Viral immune modulators perturb the human molecular network by common and unique strategies journal July 2012
Marburg Virus Infection Detected in a Common African Bat journal August 2007
Marburg Hemorrhagic Fever Associated with Multiple Genetic Lineages of Virus journal August 2006
Interferon-Stimulated Genes: A Complex Web of Host Defenses journal March 2014
Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism journal September 2012
Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus journal January 2011
Mechanisms and Consequences of Ebolavirus-Induced Lymphocyte Apoptosis journal December 2009
Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus journal January 2010
The Tyro3 Receptor Kinase Axl Enhances Macropinocytosis of Zaire Ebolavirus journal November 2010
Coping with stress: eIF2 kinases and translational control journal January 2006
Tyro3 Family-Mediated Cell Entry of Ebola and Marburg Viruses journal September 2006
Inflammatory responses in Ebola virus-infected patients journal April 2002
Monocyte-Derived Human Macrophages and Peripheral Blood Mononuclear Cells Infected with Ebola Virus Secrete MIP-1α and TNF-α and Inhibit Poly-IC-Induced IFN-α in Vitro journal May 2001
The Keap1–Nrf2 Cell Defense Pathway – A Promising Therapeutic Target? book January 2012
Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein journal October 2005
The Ins and Outs of STAT1 Nuclear Transport journal August 2003

Cited By (35)

Alphavirus Replicon DNA Vectors Expressing Ebola GP and VP40 Antigens Induce Humoral and Cellular Immune Responses in Mice journal January 2018
Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion journal May 2019
Therapeutic strategies to target the Ebola virus life cycle journal July 2019
Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies journal March 2019
Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction text January 2016
Immune parameters and outcomes during Ebola virus disease journal January 2019
Erratum: Post-exposure treatments for Ebola and Marburg virus infections journal May 2018
Retinal Pigment Epithelial Cells are a Potential Reservoir for Ebola Virus in the Human Eye journal July 2017
Role of Type I Interferons on Filovirus Pathogenesis journal February 2019
A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism journal April 2018
Unique human immune signature of Ebola virus disease in Guinea journal May 2016
Ebola Immunity: Gaining a Winning Position in Lightning Chess journal July 2018
Post-exposure treatments for Ebola and Marburg virus infections journal January 2018
When Dendritic Cells Go Viral: The Role of Siglec-1 in Host Defense and Dissemination of Enveloped Viruses journal December 2019
Receptor-Mediated Host Cell Preference of a Bat-Derived Filovirus, Lloviu Virus journal October 2020
In vivo Ebola virus infection leads to a strong innate response in circulating immune cells journal September 2016
Global research trends of World Health Organization’s top eight emerging pathogens journal February 2017
Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction journal November 2016
Aerosol Transmission of Filoviruses journal May 2016
Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses journal February 2016
The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses journal December 2016
Monoclonal antibodies for the treatment of Ebola virus disease journal October 2016
Disabling of lymphocyte immune response by Ebola virus journal April 2018
Mécanismes d’échappement des filovirus à l’immunité innée journal August 2018
Ebola virus VP30 and nucleoprotein interactions modulate viral RNA synthesis journal June 2017
Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques journal January 2019
Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles journal August 2018
Bats and Viruses: Emergence of Novel Lyssaviruses and Association of Bats with Viral Zoonoses in the EU journal February 2019
The roles of ebolavirus glycoproteins in viral pathogenesis journal November 2016
Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions journal January 2017
Melatonin as an antioxidant: under promises but over delivers journal September 2016
Persistence and Sexual Transmission of Filoviruses journal December 2018
The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing journal June 2017
The ongoing evolution of antibody-based treatments for Ebola virus infection journal March 2017
Phenotypic Prioritization of Diphyllin Derivatives That Block Filoviral Cell Entry by Vacuolar (H + )-ATPase Inhibition journal November 2018